Skip to main content
. 2014 Nov 18;2014:720507. doi: 10.1155/2014/720507

Table 2.

Average adjusted resting blood pressure change (mean ± SEM) after 6 mo of 80 mg atorvastatin or placebo among total sample and by drug and sex.

Resting BP (mmHg) Total sample Atorvastatin Placebo
Pre Δ Pre Δ Pre Δ
Total n = 419 n = 202 n = 217
 SBP 118.9 ± 0.6 0.5 ± 0.5 115.3 ± 0.9 0.8 ± 0.7 114.7 ± 0.8 0.3 ± 0.6
 DBP 75.3 ± 0.5 0.3 ± 0.5 75.5 ± 0.6 0.4 ± 0.7 75.2 ± 0.6 0.5 ± 0.6
 MAP 87.7 ± 0.7 0.2 ± 0.8 88.5 ± 0.8 0.0 ± 0.8 86.8 ± 1.1 0.5 ± 1.3
Men n = 203 n = 99 n = 104
 SBP 117.2 ± 0.8 1.2 ± 0.7 117.7 ± 1.2 2.7 ± 1.0 116.6 ± 1.1 −0.2 ± 1.0
 DBP 76.5 ± 0.6 1.0 ± 0.7 75.0 ± 0.9 2.0 ± 1.0 77.0 ± 0.9 0.2 ± 0.9
 MAP 89.3 ± 1.0 1.2 ± 1.0 90.1 ± 0.9 0.9 ± 1.2 87.7 ± 1.6 1.7 ± 1.8
Women n = 216 n = 102 n = 113
 SBP 113.0 ± 0.8* −0.1 ± 0.7 113.0 ± 1.2* −1.0 ± 1.1* 113.0 ± 1.2* 0.8 ± 0.8
 DBP 74.3 ± 0.6* −0.4 ± 0.7 76.0 ± 0.9* −1.2 ± 0.9* 73.4 ± 0.9∗‡ 0.8 ± 0.9
 MAP 86.1 ± 0.9* −0.7 ± 1.2 86.9 ± 0.9* −0.8 ± 1.2 85.9 ± 1.5* −0.7 ± 1.8

Adjusted for age, baseline BMI, baseline VO2peak, and sex.

Pre, baseline; Δ, after 6 months; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure.

* P < 0.05; men versus women.

P < 0.05, atorvastatin versus placebo.